Bi­par­ti­san House group calls on FDA to en­sure OTC and pre­scrip­tion ver­sions of a drug can­not be mar­ket­ed si­mul­ta­ne­ous­ly

Reps. Deb­bie Din­gell (D-MI), Robert Lat­ta (R-OH) and Dan Cren­shaw (R-TX) sent a let­ter yes­ter­day to Pa­trizia Cavaz­zoni, the head of FDA’s Cen­ter for Drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.